Cargando…
Rest/stress myocardial perfusion imaging by positron emission tomography with (18)F-Flurpiridaz: A feasibility study in mice
BACKGROUND: Myocardial perfusion imaging by positron emission tomography (PET-MPI) is the current gold standard for quantification of myocardial blood flow. (18)F-flurpiridaz was recently introduced as a valid alternative to currently used PET-MPI probes. Nonetheless, optimum scan duration and time...
Autores principales: | , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9984310/ https://www.ncbi.nlm.nih.gov/pubmed/35484467 http://dx.doi.org/10.1007/s12350-022-02968-9 |
_version_ | 1784900719308963840 |
---|---|
author | Bengs, Susan Warnock, Geoffrey I. Portmann, Angela Mikail, Nidaa Rossi, Alexia Ahmed, Hazem Etter, Dominik Treyer, Valerie Gisler, Livio Pfister, Stefanie K. Jie, Caitlin V. M. L. Meisel, Alexander Keller, Claudia Liang, Steven H. Schibli, Roger Mu, Linjing Buechel, Ronny R. Kaufmann, Philipp A. Ametamey, Simon M. Gebhard, Catherine Haider, Ahmed |
author_facet | Bengs, Susan Warnock, Geoffrey I. Portmann, Angela Mikail, Nidaa Rossi, Alexia Ahmed, Hazem Etter, Dominik Treyer, Valerie Gisler, Livio Pfister, Stefanie K. Jie, Caitlin V. M. L. Meisel, Alexander Keller, Claudia Liang, Steven H. Schibli, Roger Mu, Linjing Buechel, Ronny R. Kaufmann, Philipp A. Ametamey, Simon M. Gebhard, Catherine Haider, Ahmed |
author_sort | Bengs, Susan |
collection | PubMed |
description | BACKGROUND: Myocardial perfusion imaging by positron emission tomography (PET-MPI) is the current gold standard for quantification of myocardial blood flow. (18)F-flurpiridaz was recently introduced as a valid alternative to currently used PET-MPI probes. Nonetheless, optimum scan duration and time interval for image analysis are currently unknown. Further, it is unclear whether rest/stress PET-MPI with (18)F-flurpiridaz is feasible in mice. METHODS: Rest/stress PET-MPI was performed with (18)F-flurpiridaz (0.6-3.0 MBq) in 27 mice aged 7–8 months. Regadenoson (0.1 µg/g) was used for induction of vasodilator stress. Kinetic modeling was performed using a metabolite-corrected arterial input function. Image-derived myocardial (18)F-flurpiridaz uptake was assessed for different time intervals by placing a volume of interest in the left ventricular myocardium. RESULTS: Tracer kinetics were best described by a two-tissue compartment model. K(1) ranged from 6.7 to 20.0 mL·cm(−3)·min(−1), while myocardial volumes of distribution (V(T)) were between 34.6 and 83.6 mL·cm(−3). Of note, myocardial (18)F-flurpiridaz uptake (%ID/g) was significantly correlated with K(1) at rest and following pharmacological vasodilation for all time intervals assessed. However, while Spearman’s coefficients (r(s)) ranged between 0.478 and 0.681, R(2) values were generally low. In contrast, an excellent correlation of myocardial (18)F-flurpiridaz uptake with V(T) was obtained, particularly when employing the averaged myocardial uptake from 20 to 40 min post tracer injection (R(2) ≥ 0.98). Notably, K(1) and V(T) were similarly sensitive to pharmacological vasodilation induction. Further, mean stress-to-rest ratios of K(1), V(T), and %ID/g (18)F-flurpiridaz were virtually identical, suggesting that %ID/g (18)F-flurpiridaz can be used to estimate coronary flow reserve (CFR) in mice. CONCLUSION: Our findings suggest that a simplified assessment of relative myocardial perfusion and CFR, based on image-derived tracer uptake, is feasible with (18)F-flurpiridaz in mice, enabling high-throughput mechanistic CFR studies in rodents. SUPPLEMENTARY INFORMATION: The online version of this article contains supplementary material available (10.1007/s12350-022-02968-9). |
format | Online Article Text |
id | pubmed-9984310 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-99843102023-03-05 Rest/stress myocardial perfusion imaging by positron emission tomography with (18)F-Flurpiridaz: A feasibility study in mice Bengs, Susan Warnock, Geoffrey I. Portmann, Angela Mikail, Nidaa Rossi, Alexia Ahmed, Hazem Etter, Dominik Treyer, Valerie Gisler, Livio Pfister, Stefanie K. Jie, Caitlin V. M. L. Meisel, Alexander Keller, Claudia Liang, Steven H. Schibli, Roger Mu, Linjing Buechel, Ronny R. Kaufmann, Philipp A. Ametamey, Simon M. Gebhard, Catherine Haider, Ahmed J Nucl Cardiol Original Article BACKGROUND: Myocardial perfusion imaging by positron emission tomography (PET-MPI) is the current gold standard for quantification of myocardial blood flow. (18)F-flurpiridaz was recently introduced as a valid alternative to currently used PET-MPI probes. Nonetheless, optimum scan duration and time interval for image analysis are currently unknown. Further, it is unclear whether rest/stress PET-MPI with (18)F-flurpiridaz is feasible in mice. METHODS: Rest/stress PET-MPI was performed with (18)F-flurpiridaz (0.6-3.0 MBq) in 27 mice aged 7–8 months. Regadenoson (0.1 µg/g) was used for induction of vasodilator stress. Kinetic modeling was performed using a metabolite-corrected arterial input function. Image-derived myocardial (18)F-flurpiridaz uptake was assessed for different time intervals by placing a volume of interest in the left ventricular myocardium. RESULTS: Tracer kinetics were best described by a two-tissue compartment model. K(1) ranged from 6.7 to 20.0 mL·cm(−3)·min(−1), while myocardial volumes of distribution (V(T)) were between 34.6 and 83.6 mL·cm(−3). Of note, myocardial (18)F-flurpiridaz uptake (%ID/g) was significantly correlated with K(1) at rest and following pharmacological vasodilation for all time intervals assessed. However, while Spearman’s coefficients (r(s)) ranged between 0.478 and 0.681, R(2) values were generally low. In contrast, an excellent correlation of myocardial (18)F-flurpiridaz uptake with V(T) was obtained, particularly when employing the averaged myocardial uptake from 20 to 40 min post tracer injection (R(2) ≥ 0.98). Notably, K(1) and V(T) were similarly sensitive to pharmacological vasodilation induction. Further, mean stress-to-rest ratios of K(1), V(T), and %ID/g (18)F-flurpiridaz were virtually identical, suggesting that %ID/g (18)F-flurpiridaz can be used to estimate coronary flow reserve (CFR) in mice. CONCLUSION: Our findings suggest that a simplified assessment of relative myocardial perfusion and CFR, based on image-derived tracer uptake, is feasible with (18)F-flurpiridaz in mice, enabling high-throughput mechanistic CFR studies in rodents. SUPPLEMENTARY INFORMATION: The online version of this article contains supplementary material available (10.1007/s12350-022-02968-9). Springer International Publishing 2022-04-28 2023 /pmc/articles/PMC9984310/ /pubmed/35484467 http://dx.doi.org/10.1007/s12350-022-02968-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Article Bengs, Susan Warnock, Geoffrey I. Portmann, Angela Mikail, Nidaa Rossi, Alexia Ahmed, Hazem Etter, Dominik Treyer, Valerie Gisler, Livio Pfister, Stefanie K. Jie, Caitlin V. M. L. Meisel, Alexander Keller, Claudia Liang, Steven H. Schibli, Roger Mu, Linjing Buechel, Ronny R. Kaufmann, Philipp A. Ametamey, Simon M. Gebhard, Catherine Haider, Ahmed Rest/stress myocardial perfusion imaging by positron emission tomography with (18)F-Flurpiridaz: A feasibility study in mice |
title | Rest/stress myocardial perfusion imaging by positron emission tomography with (18)F-Flurpiridaz: A feasibility study in mice |
title_full | Rest/stress myocardial perfusion imaging by positron emission tomography with (18)F-Flurpiridaz: A feasibility study in mice |
title_fullStr | Rest/stress myocardial perfusion imaging by positron emission tomography with (18)F-Flurpiridaz: A feasibility study in mice |
title_full_unstemmed | Rest/stress myocardial perfusion imaging by positron emission tomography with (18)F-Flurpiridaz: A feasibility study in mice |
title_short | Rest/stress myocardial perfusion imaging by positron emission tomography with (18)F-Flurpiridaz: A feasibility study in mice |
title_sort | rest/stress myocardial perfusion imaging by positron emission tomography with (18)f-flurpiridaz: a feasibility study in mice |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9984310/ https://www.ncbi.nlm.nih.gov/pubmed/35484467 http://dx.doi.org/10.1007/s12350-022-02968-9 |
work_keys_str_mv | AT bengssusan reststressmyocardialperfusionimagingbypositronemissiontomographywith18fflurpiridazafeasibilitystudyinmice AT warnockgeoffreyi reststressmyocardialperfusionimagingbypositronemissiontomographywith18fflurpiridazafeasibilitystudyinmice AT portmannangela reststressmyocardialperfusionimagingbypositronemissiontomographywith18fflurpiridazafeasibilitystudyinmice AT mikailnidaa reststressmyocardialperfusionimagingbypositronemissiontomographywith18fflurpiridazafeasibilitystudyinmice AT rossialexia reststressmyocardialperfusionimagingbypositronemissiontomographywith18fflurpiridazafeasibilitystudyinmice AT ahmedhazem reststressmyocardialperfusionimagingbypositronemissiontomographywith18fflurpiridazafeasibilitystudyinmice AT etterdominik reststressmyocardialperfusionimagingbypositronemissiontomographywith18fflurpiridazafeasibilitystudyinmice AT treyervalerie reststressmyocardialperfusionimagingbypositronemissiontomographywith18fflurpiridazafeasibilitystudyinmice AT gislerlivio reststressmyocardialperfusionimagingbypositronemissiontomographywith18fflurpiridazafeasibilitystudyinmice AT pfisterstefaniek reststressmyocardialperfusionimagingbypositronemissiontomographywith18fflurpiridazafeasibilitystudyinmice AT jiecaitlinvml reststressmyocardialperfusionimagingbypositronemissiontomographywith18fflurpiridazafeasibilitystudyinmice AT meiselalexander reststressmyocardialperfusionimagingbypositronemissiontomographywith18fflurpiridazafeasibilitystudyinmice AT kellerclaudia reststressmyocardialperfusionimagingbypositronemissiontomographywith18fflurpiridazafeasibilitystudyinmice AT liangstevenh reststressmyocardialperfusionimagingbypositronemissiontomographywith18fflurpiridazafeasibilitystudyinmice AT schibliroger reststressmyocardialperfusionimagingbypositronemissiontomographywith18fflurpiridazafeasibilitystudyinmice AT mulinjing reststressmyocardialperfusionimagingbypositronemissiontomographywith18fflurpiridazafeasibilitystudyinmice AT buechelronnyr reststressmyocardialperfusionimagingbypositronemissiontomographywith18fflurpiridazafeasibilitystudyinmice AT kaufmannphilippa reststressmyocardialperfusionimagingbypositronemissiontomographywith18fflurpiridazafeasibilitystudyinmice AT ametameysimonm reststressmyocardialperfusionimagingbypositronemissiontomographywith18fflurpiridazafeasibilitystudyinmice AT gebhardcatherine reststressmyocardialperfusionimagingbypositronemissiontomographywith18fflurpiridazafeasibilitystudyinmice AT haiderahmed reststressmyocardialperfusionimagingbypositronemissiontomographywith18fflurpiridazafeasibilitystudyinmice |